Rep. Thomas Teams Up With Insmed To Promote Follow-on Biologics
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Rep. Bill Thomas continues his crusade for follow-ons and against Amgen in his new role as consultant to Richmond, Va.-based Insmed, which has big plans for follow-on biologics.